WIA
ARKG icon

Wetzel Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Wetzel Investment Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-278
Closed -$9K – 1059
2023
Q4 		$9K Buy
+278
New +$7.56K 0.01% 537

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wetzel Investment Advisors's ARKG Position: Q1 2024 in Review

Wetzel Investment Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 278 shares — an estimated $9K sold.

Wetzel Investment Advisors first reported a position in ARKG in Q4 2023 and held it in 1 quarter. The position peaked at $9K in Q4 2023. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Wetzel Investment Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 278 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $9K.
  • Wetzel Investment Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 1 quarter.
  • Wetzel Investment Advisors's ARK Genomic Revolution ETF position peaked at $9K in Q4 2023.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Wetzel Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.